GB2160861B - Prazosin hydrochloride - Google Patents

Prazosin hydrochloride

Info

Publication number
GB2160861B
GB2160861B GB08424999A GB8424999A GB2160861B GB 2160861 B GB2160861 B GB 2160861B GB 08424999 A GB08424999 A GB 08424999A GB 8424999 A GB8424999 A GB 8424999A GB 2160861 B GB2160861 B GB 2160861B
Authority
GB
United Kingdom
Prior art keywords
prazosin hydrochloride
prazosin
hydrochloride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB08424999A
Other languages
English (en)
Other versions
GB2160861A (en
GB8424999D0 (en
Inventor
Stig Olof Engelbert Lindholm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orion Oyj
Fermion Oy
Original Assignee
Orion Yhtyma Fermion Oy
Orion Yhtyma Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtyma Fermion Oy, Orion Yhtyma Oy filed Critical Orion Yhtyma Fermion Oy
Publication of GB8424999D0 publication Critical patent/GB8424999D0/en
Publication of GB2160861A publication Critical patent/GB2160861A/en
Application granted granted Critical
Publication of GB2160861B publication Critical patent/GB2160861B/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
GB08424999A 1984-06-25 1984-10-03 Prazosin hydrochloride Expired GB2160861B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI842544A FI79107C (fi) 1984-06-25 1984-06-25 Foerfarande foer framstaellning av stabil -form av prazosinhydroklorid.

Publications (3)

Publication Number Publication Date
GB8424999D0 GB8424999D0 (en) 1984-11-07
GB2160861A GB2160861A (en) 1986-01-02
GB2160861B true GB2160861B (en) 1987-11-18

Family

ID=8519293

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08424999A Expired GB2160861B (en) 1984-06-25 1984-10-03 Prazosin hydrochloride

Country Status (17)

Country Link
US (2) US4739055A (enExample)
JP (1) JPS6115881A (enExample)
AT (1) AT389117B (enExample)
AU (1) AU566814B2 (enExample)
BE (1) BE900925A (enExample)
CH (1) CH661045A5 (enExample)
DE (1) DE3429415A1 (enExample)
FI (1) FI79107C (enExample)
FR (1) FR2567124B1 (enExample)
GB (1) GB2160861B (enExample)
IL (1) IL73267A (enExample)
IT (1) IT1224142B (enExample)
LU (1) LU85616A1 (enExample)
NL (1) NL8403250A (enExample)
NZ (1) NZ209962A (enExample)
PT (1) PT79411B (enExample)
ZA (1) ZA85910B (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0237608B1 (de) * 1986-03-21 1992-01-29 HEUMANN PHARMA GMBH & CO Kristalline, wasserfreie Sigma -Form von 2-[4-(2-Furoyl-(2-piperazin)-1-yl]-4-amino-6,7-dimethoxychinazolinhydrochlorid und Verfahren zu ihrer Herstellung
JP2756846B2 (ja) * 1989-12-28 1998-05-25 住化ファインケム株式会社 無水のε型結晶体２―〔４―（２―フロイル）ピペラジン―１―イル〕―４―アミノ―６，７―ジメトキシキナゾリン塩酸塩及びその製造方法
JPH07206857A (ja) * 1993-12-28 1995-08-08 Synthelabo Sa アルフゾシン塩酸塩の二水和物
EE05643B1 (et) * 2001-02-24 2013-04-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ksantiini derivaadid, nende valmistamine ja kasutamine ravimina
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
US7501426B2 (en) * 2004-02-18 2009-03-10 Boehringer Ingelheim International Gmbh 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004054054A1 (de) 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
DE102005035891A1 (de) * 2005-07-30 2007-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
EP1852108A1 (en) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
CN102838599A (zh) 2006-05-04 2012-12-26 贝林格尔.英格海姆国际有限公司 多晶型
PE20080251A1 (es) 2006-05-04 2008-04-25 Boehringer Ingelheim Int Usos de inhibidores de dpp iv
AU2008290582B2 (en) * 2007-08-17 2014-08-14 Boehringer Ingelheim International Gmbh Purin derivatives for use in the treatment of fab-related diseases
PE20091730A1 (es) 2008-04-03 2009-12-10 Boehringer Ingelheim Int Formulaciones que comprenden un inhibidor de dpp4
PE20100156A1 (es) * 2008-06-03 2010-02-23 Boehringer Ingelheim Int Tratamiento de nafld
KR20200118243A (ko) 2008-08-06 2020-10-14 베링거 인겔하임 인터내셔날 게엠베하 메트포르민 요법이 부적합한 환자에서의 당뇨병 치료
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
MX370599B (es) * 2008-08-15 2019-12-18 Boehringer Ingelheim Int Derivados de purina para su uso en el tratamiento de enfermedades relacionadas con fab.
BRPI0919288A2 (pt) 2008-09-10 2015-12-15 Boehring Ingelheim Internat Gmbh teriapia de combinação para tratamento de diabetes e condições relacionadas.
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
EA022310B1 (ru) 2008-12-23 2015-12-30 Бёрингер Ингельхайм Интернациональ Гмбх Солевые формы органического соединения
AR074990A1 (es) 2009-01-07 2011-03-02 Boehringer Ingelheim Int Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina
NZ599298A (en) 2009-11-27 2014-11-28 Boehringer Ingelheim Int Treatment of genotyped diabetic patients with dpp-iv inhibitors such as linagliptin
WO2011138421A1 (en) 2010-05-05 2011-11-10 Boehringer Ingelheim International Gmbh Combination therapy
NZ603319A (en) 2010-06-24 2015-04-24 Boehringer Ingelheim Int Diabetes therapy
AR083878A1 (es) 2010-11-15 2013-03-27 Boehringer Ingelheim Int Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento
CA2841552C (en) 2011-07-15 2020-06-23 Boehringer Ingelheim International Gmbh Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
US20130303554A1 (en) 2012-05-14 2013-11-14 Boehringer Ingelheim International Gmbh Use of a dpp-4 inhibitor in sirs and/or sepsis
EP3685839A1 (en) 2012-05-14 2020-07-29 Boehringer Ingelheim International GmbH Linagliptin for use in the treatment of albuminuria and kidney related diseases
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
ES2950384T3 (es) 2014-02-28 2023-10-09 Boehringer Ingelheim Int Uso médico de un inhibidor de DPP-4
WO2017211979A1 (en) 2016-06-10 2017-12-14 Boehringer Ingelheim International Gmbh Combinations of linagliptin and metformin

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE156532C (enExample) *
US2969375A (en) * 1961-01-24 Certification of correction
NL54420C (enExample) * 1937-05-25
GB1156973A (en) * 1965-07-06 1969-07-02 Quinazoline Derivatives
US3433788A (en) * 1966-04-27 1969-03-18 Union Carbide Corp Process for recovery of amines from aqueous solutions by solvent treatment and distillation
US3421983A (en) * 1967-03-07 1969-01-14 Lummus Co Azeotropic distillation of aqueous toluene diamine
US3511836A (en) * 1967-12-13 1970-05-12 Pfizer & Co C 2,4,6,7-tetra substituted quinazolines
US3743672A (en) * 1970-05-27 1973-07-03 Halcon International Inc Separation of water in alkylene glycol mono and diester purification by azeotropic distillation
GB1308718A (en) * 1970-07-01 1973-03-07 Sir Soc Italiana Resine Spa Method of separating vinyl acetate from liquid mixtures
IT956765B (it) * 1972-06-22 1973-10-10 Montedison Spa Procedimento per la purificazione di 1 3 diossolano
US3935213A (en) * 1973-12-05 1976-01-27 Pfizer Inc. Process for hypotensive 4-amino-2-(piperazin-1-yl) quinazoline derivatives
US4026894A (en) * 1975-10-14 1977-05-31 Abbott Laboratories Antihypertensive agents
US4001237A (en) * 1976-02-18 1977-01-04 Bristol-Myers Company Oxazole, isoxazole, thiazole and isothiazole amides
US4092315A (en) * 1976-03-01 1978-05-30 Pfizer Inc. Novel crystalline forms of prazosin hydrochloride
FI67699C (fi) * 1979-01-31 1985-05-10 Orion Yhtymae Oy Foerfarande foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolinhydroklorid med blodtryckssaenkande verkan
FI64367C (fi) * 1980-02-26 1986-08-05 Orion Yhtymae Oy Foerfarande foer framstaellning av alfa-form av prazosinhydroklorid

Also Published As

Publication number Publication date
ZA85910B (en) 1985-09-25
JPH0481993B2 (enExample) 1992-12-25
BE900925A (fr) 1985-02-15
DE3429415C2 (enExample) 1990-05-03
GB2160861A (en) 1986-01-02
FI842544A0 (fi) 1984-06-25
FR2567124B1 (fr) 1990-09-21
CH661045A5 (de) 1987-06-30
PT79411B (en) 1986-09-15
IL73267A (en) 1988-06-30
FI79107C (fi) 1989-11-10
US4873330A (en) 1989-10-10
ATA344184A (de) 1989-03-15
AU566814B2 (en) 1987-10-29
NL8403250A (nl) 1986-01-16
FI79107B (fi) 1989-07-31
PT79411A (en) 1984-11-01
NZ209962A (en) 1987-06-30
JPS6115881A (ja) 1986-01-23
FR2567124A1 (fr) 1986-01-10
IT1224142B (it) 1990-09-26
GB8424999D0 (en) 1984-11-07
LU85616A1 (fr) 1985-06-04
AU3451084A (en) 1986-01-02
US4739055A (en) 1988-04-19
FI842544L (fi) 1985-12-26
IT8423292A0 (it) 1984-10-24
AT389117B (de) 1989-10-25
DE3429415A1 (de) 1986-01-02
IL73267A0 (en) 1985-01-31

Similar Documents

Publication Publication Date Title
GB8424999D0 (en) Prazosin hydrochloride
GB8506474D0 (en) Producing diphenylamines
AU95743S (en) Telelphone set
EP0183535A3 (en) Self-correcting printer-verifier
GB8530186D0 (en) Supports
PH21512A (en) N-(naphthyl-alkyl)-hydroxy-amines
GB8415254D0 (en) Amine derivatives
ZA85116B (en) 3-alkoxy-2-(n-pyrrolidino)-n-pyrimidinyl-or-n-pyrazinylpropylamines
GB8407957D0 (en) Golf
GB2166657B (en) Golf aid
GB8514417D0 (en) Preparing aminobenzylamine
ZA85274B (en) N-(naphthyl-alkyl)-hydroxylamines
GB8426229D0 (en) Putting aid
YU40084A (en) Hidraulic soft constant cateter
GB8530759D0 (en) 2-nitro-4-amino anilines
CS867284A1 (en) Sposob stanovenia obsahu n nitrozodimetylaminu
GB8416158D0 (en) Amines
NZ227556A (en) 1-alkoxy-1-methylethoxy amines
KR860000566Y1 (en) Golf-club
GB8423937D0 (en) Aminoalkanols
GB8410346D0 (en) Putting aid
GB8425472D0 (en) Golfers aid
CS595084A1 (en) Sposob chromatografickej izolacie alditolov z ich zmesi
GB8401272D0 (en) Polyamines
BG38181A1 (en) Antimycotic means

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20021003